OpenURL Connection Search

Select item for more details and to access through your institution.

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.
Published in:
2016
By:
- Voss, Tiffini;
- Lipton, Richard B.;
- Dodick, David W.;
- Dupre, Nicole;
- Joy Yang Ge;
- Bachman, Robert;
- Assaid, Christopher;
- Aurora, Sheena K.;
- Michelson, David;
- Ge, Joy Yang
Publication type:
journal article
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine.
Published in:
2016
By:
- Ho, Tony W.;
- Ho, Andrew P.;
- Ge, Yang (Joy);
- Assaid, Christopher;
- Gottwald, Regina;
- MacGregor, E. Anne;
- Mannix, Lisa K.;
- van Oosterhout, Willebrordus P. J.;
- Koppenhaver, Janelle;
- Lines, Christopher;
- Ferrari, Michel D.;
- Michelson, David
Publication type:
journal article
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
Published in:
2011
By:
- Hewitt DJ;
- Aurora SK;
- Dodick DW;
- Goadsby PJ;
- Ge YJ;
- Bachman R;
- Taraborelli D;
- Fan X;
- Assaid C;
- Lines C;
- Ho TW;
- Hewitt, David J;
- Aurora, Sheena K;
- Dodick, David W;
- Goadsby, Peter J;
- Ge, Yang Joy;
- Bachman, Robert;
- Taraborelli, Donna;
- Fan, Xiaoyin;
- Assaid, Christopher
Publication type:
journal article
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.
Published in:
Cephalalgia, 2011, v. 31, n. 6, p. 712, doi. 10.1177/0333102411398399
By:
- Hewitt, David J;
- Aurora, Sheena K;
- Dodick, David W;
- Goadsby, Peter J;
- Ge, Yang (Joy);
- Bachman, Robert;
- Taraborelli, Donna;
- Fan, Xiaoyin;
- Assaid, Christopher;
- Lines, Christopher;
- Ho, Tony W
Publication type:
Article
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.
Published in:
Dermatology & Therapy, 2023, v. 13, n. 12, p. 3165, doi. 10.1007/s13555-023-01059-y
By:
- Bratland, Åse;
- Munoz-Couselo, Eva;
- Mortier, Laurent;
- Roshdy, Osama;
- González, Rene;
- Schachter, Jacob;
- Arance, Ana M.;
- Grange, Florent;
- Meyer, Nicolas;
- Joshi, Abhishek Jagdish;
- Billan, Salem;
- Hughes, Brett G. M.;
- Grob, Jean-Jacques;
- Ramakrishnan, Karthik;
- Ge, Joy;
- Gumuscu, Burak;
- Swaby, Ramona F.;
- Gutzmer, Ralf
Publication type:
Article
Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.
Published in:
BMC Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11316-0
By:
- Cho, Byoung Chul;
- Braña, Irene;
- Cirauqui, Beatriz;
- Aksoy, Sercan;
- Couture, Felix;
- Hong, Ruey-Long;
- Miller Jr, Wilson H.;
- Chaves-Conde, Manuel;
- Teixeira, Margarida;
- Leopold, Lance;
- Munteanu, Mihaela;
- Ge, Joy Yang;
- Swaby, Ramona F.;
- Hughes, Brett G. M.
Publication type:
Article

Found: 6

A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine.

Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine.

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine.

Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629.

Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.